+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Gastrointestinal Drugs Market Research Reports

From
From
From
From
From
From
From
From
GIMOTI Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

GIMOTI Sales Forecast and Market Size Analysis - 2034

  • Report
  • May 2026
  • 30 Pages
  • Global
From
Lipodystrophy - Pipeline Insight, 2026 - Product Thumbnail Image

Lipodystrophy - Pipeline Insight, 2026

  • Clinical Trials
  • May 2026
  • 60 Pages
  • Global
From
From
Hypoglycemia - Pipeline Insight, 2026 - Product Thumbnail Image

Hypoglycemia - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 180 Pages
  • Global
From
Irritable Bowel Syndrome - Pipeline Insight, 2026 - Product Thumbnail Image

Irritable Bowel Syndrome - Pipeline Insight, 2026

  • Clinical Trials
  • April 2026
  • 80 Pages
  • Global
From
From
JORVEZA Sales Forecast and Market Size Analysis - 2034 - Product Thumbnail Image

JORVEZA Sales Forecast and Market Size Analysis - 2034

  • Report
  • March 2026
  • 30 Pages
  • Global
From
From
From
Loading Indicator

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists. The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more